 Analgesics
|
Anesthetics
|
Anti-Addiction/Substance Abuse Treatment Agents
|
Antibacterials
|
Anticonvulsants
|
Antidementia Agents
|
Antidepressants
|
Antiemetics
|
Antifungals
|
Antigout Agents
|
 Antimigraine Agents
|
Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonist
|
Atogepant
|
 D11313 Atogepant (USAN)
|
Eptinezumab
|
D11303 Eptinezumab (USAN)
|
Erenumab
|
D10928 Erenumab (USAN/INN)
|
Fremanezumab
|
D11055 Fremanezumab (USAN/INN)
|
Galcanezumab
|
D10936 Galcanezumab (USAN/INN)
|
Rimegepant [DG:DG01845]
|
D10663 Rimegepant sulfate (USAN)
|
Ubrogepant
|
D10673 Ubrogepant (USAN/INN)
|
Zavegepant [DG:DG03122]
|
D11899 Zavegepant hydrochloride (USAN)
|
Ergot Alkaloids
|
Serotonin (5-HT) Receptor Agonists
|
Antimigraine Agents, Other
|
Antimyasthenic Agents
|
Antimycobacterials
|
Antineoplastics
|
Anti-Obesity Agents
|
Antiparasitics
|
Antiparkinson Agents
|
Antipsychotics
|
Antispasticity Agents
|
Antivirals
|
Anxiolytics
|
Bipolar Agents
|
Blood Glucose Regulators
|
Blood Products and Modifiers
|
Cardiovascular Agents
|
Central Nervous System Agents
|
Contraceptives
|
Dental and Oral Agents
|
Dermatological Agents
|
Electrolytes/Minerals/Metals/Vitamins
|
Gastrointestinal Agents
|
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
|
Genitourinary Agents
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
Hormonal Agents, Suppressant (Pituitary)
|
Hormonal Agents, Suppressant (Thyroid)
|
Immunological Agents
|
Infertility Agents
|
Inflammatory Bowel Disease Agents
|
Kidney Agents
|
Metabolic Bone Disease Agents
|
Bisphosphonates
|
Calcium Regulating Hormones
|
Calcium-sensing Receptor Agonist
|
RANK Ligand Inhibitors
|
Sclerostin Inhibitors
|
Vitamin D-related Agents
|
Calcifediol [DG:DG00124]
|
D00122 Calcifediol (USP/INN)
|
Calcitriol
|
D00129 Calcitriol (JAN/USP/INN)
|
Doxercalciferol
|
D01009 Doxercalciferol (USAN/INN)
|
Paricalcitol
|
D00930 Paricalcitol (JAN/USP/INN)
|
Ophthalmic Agents
|
Otic Agents
|
Respiratory Tract/Pulmonary Agents
|
Sexual Disorder Agents
|
Skeletal Muscle Relaxants
|
Abobotulinumtoxin A
|
D09764 AbobotulinumtoxinA (USAN)
|
Aspirin/ Caffeine/ Orphenadrine Citrate
|
D11849 Orphenadrine citrate, aspirin and caffeine
|
Aspirin/ Carisoprodol/ Codeine Phosphate
|
D11587 Carisoprodol, aspirin and codeine phosphate
|
Carisoprodol
|
D00768 Carisoprodol (JAN/USP/INN)
|
Chlorzoxazone
|
D00771 Chlorzoxazone (JAN/USP/INN)
|
Cyclobenzaprine [DG:DG00775]
|
D00772 Cyclobenzaprine hydrochloride (USP)
|
Incobotulinumtoxin A
|
D10012 Incobotulinumtoxin A (JAN/USAN)
|
Metaxalone
|
D00773 Metaxalone (USP/INN)
|
Methocarbamol
|
D00402 Methocarbamol (JAN/USP/INN)
|
Orphenadrine [DG:DG01252]
|
D00774 Orphenadrine citrate (USP)
D02599 Orphenadrine hydrochloride
|
Rimabotulinumtoxin B
|
D02735 RimabotulinumtoxinB (USAN)
|
Sleep Disorder Agents
|
USP Drug Classification